Randomised, blinded clinical study to assess the immunogenicity and reactogenicity of SB Biologicals' dTpa and DTPa vaccines and a commercial Td vaccine administered as a booster dose to healthy children 4 to 6 years old, previously vaccinated with four doses of SB Biologicals' DTPa vaccine in the first two years of life

Trial Profile

Randomised, blinded clinical study to assess the immunogenicity and reactogenicity of SB Biologicals' dTpa and DTPa vaccines and a commercial Td vaccine administered as a booster dose to healthy children 4 to 6 years old, previously vaccinated with four doses of SB Biologicals' DTPa vaccine in the first two years of life

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2006

At a glance

  • Drugs Diphtheria-tetanus vaccine; DTaP vaccine; Pertussis acellular vaccine
  • Indications Diphtheria; Pertussis; Tetanus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top